R. Jakacki

发表

Restrictive lung disease following treatment for malignant brain tumors: a potential late effect of craniospinal irradiation.

R. Jakacki, C. Schramm, B. Donahue, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased risk of cardiac dysfunction after anthracyclines in girls.

J. Silber, J. Goldwein, G. Barber, 1993, Medical and pediatric oncology.

Comparison of cardiac function tests after anthracycline therapy in childhood implications for screening

J. Silber, M. Fridman, G. Barber, 1993, Cancer.

Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.

M. Mehta, T. Zhou, I. Pollack, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Objective response of multiply recurrent low‐grade gliomas to bevacizumab and irinotecan

T. MacDonald, Michael Fisher, R. Packer, 2009, Pediatric blood & cancer.

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.

David T. W. Jones, A. Panigrahy, S. Pfister, 2019, The Lancet. Oncology.

A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.

M. Prados, T. Zhou, R. Timmerman, 2008, Neuro-oncology.

Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas

S. Steinberg, I. Pollack, J. Fangusaro, 2016, Neuro-oncology.

Bevacizumab (BVZ)‐associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT‐11)

R. McLendon, I. Pollack, R. Gilbertson, 2013, Cancer.

Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.

C. Hawkins, S. Baruchel, D. Hargrave, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I study of concurrent RMP‐7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas

M. Mehta, G. Reaman, R. Packer, 2005 .

A novel SNP analysis method to detect copy number alterations with an unbiased reference signal directly from tumor samples

I. Pollack, W. LaFramboise, U. Chandran, 2011, BMC Medical Genomics.

Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood.

M. Prados, B. Lange, G. Reaman, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ketamine PCA for Treatment of End-of-Life Neuropathic Pain in Pediatrics

D. Howrie, Carol May, R. Jakacki, 2015, The American journal of hospice & palliative care.

Treatment strategies for high-risk medulloblastoma and supratentorial primitive neuroectodermal tumors. Review of the literature.

R. Jakacki, 2005, Journal of neurosurgery.

A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.

R. Timmerman, T. Luerssen, R. Jakacki, 2004, International journal of radiation oncology, biology, physics.

BRIEF REPORT The Development of Moyamoya Syndrome After Proton Beam Therapy

T. Yock, F. Khan, N. Zwagerman, 2014 .

Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumors

A. Angiolillo, A. Levy, L. Wexler, 2009, Cancer.

Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas.

A. Panigrahy, I. Pollack, L. Butterfield, 2016, Neuro-oncology.

Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study

A. Panigrahy, I. Pollack, L. Butterfield, 2016, Journal of Neuro-Oncology.

Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.

A. Panigrahy, I. Pollack, L. Butterfield, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.

A. Panigrahy, I. Pollack, S. Partap, 2020, Neuro-oncology.

A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study

M. Prados, I. Pollack, J. Fangusaro, 2017, Neuro-oncology.

Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study.

R. McLendon, I. Pollack, R. Gilbertson, 2014, Neuro-oncology.

Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma

A. Panigrahy, B. Kurland, R. Ceschin, 2015, American Journal of Neuroradiology.

Quantitative Sodium (23Na) MRI in Pediatric Gliomas: Initial Experience

J. Mountz, A. Panigrahy, I. Pollack, 2022, Diagnostics.

Optic pathway glioma as part of a constitutional mismatch‐repair deficiency syndrome in a patient meeting the criteria for neurofibromatosis type 1

I. Pollack, M. Nikiforova, R. Jaffe, 2013, Pediatric blood & cancer.

Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study.

T. Zhou, I. Pollack, G. Vezina, 2013, International journal of radiation oncology, biology, physics.

Cardiac dysfunction following spinal irradiation during childhood.

J. Silber, J. Goldwein, G. Barber, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies.

K. Caldemeyer, L. Sender, R. Jakacki, 1997, Medical and pediatric oncology.

Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.

K. Cornetta, V. Mathews, D. Williams, 1998, Medical and pediatric oncology.

Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study

S. Zacharoulis, Jiuzhou Wang, M. Kieran, 2016, Journal of Neuro-Oncology.

Pegylated interferon-α-2b for children with recurrent craniopharyngioma.

A. Panigrahy, I. Pollack, R. Jakacki, 2012, Journal of neurosurgery. Pediatrics.

Phase II evaluation of interferon α-2a for progressive or recurrent craniopharyngiomas

V. Mathews, D. Heilman, T. Luerssen, 2000 .

Extraventricular neurocytoma in neurofibromatosis Type 1: case report.

I. Pollack, R. Hamilton, G. Yeaney, 2008, Journal of neurosurgery. Pediatrics.

A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.

I. Pollack, P. Adamson, E. Bouffet, 2011, Neuro-oncology.

Pineal and nonpineal supratentorial primitive neuroectodermal tumors

R. Jakacki, 1999, Child's Nervous System.

Long‐term efficacy and toxicity of bevacizumab‐based therapy in children with recurrent low‐grade gliomas

Michael Fisher, R. Packer, G. Vezina, 2013, Pediatric blood & cancer.

Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis

A. Panigrahy, M. Nikiforova, R. Hamilton, 2015, Melanoma research.

Phase I trial of pegylated interferon-α-2b in young patients with plexiform neurofibromas

B. Widemann, E. Dombi, S. Goldman, 2011, Neurology.

Pulsatile secretion of luteinizing hormone in children.

J. Marshall, R. Kelch, R. Jakacki, 1982, The Journal of clinical endocrinology and metabolism.

Patterns of failure after induction chemotherapy followed by consolidative radiation therapy for children with central nervous system germinoma.

R. Timmerman, R. Jakacki, J. Boaz, 2003, Medical and pediatric oncology.

Haemophilus influenzae diphtheria protein conjugate immunization after therapy in splenectomized patients with Hodgkin disease.

B. Lange, R. Jakacki, P. Mcverry, 1990, Annals of internal medicine.

Phase II evaluation of topotecan for pediatric central nervous system tumors.

S. Sallan, P. Adamson, B. Lange, 1996, Cancer.

Testing the hypothalamic-pituitary-adrenal axis in survivors of childhood brain and skull-based tumors.

R. Shankar, O. Pescovitz, R. Jakacki, 1997, The Journal of clinical endocrinology and metabolism.

Phase II evaluation of topotecan for pediatric central nervous system tumors

S. Sallan, P. Adamson, B. Lange, 1996 .

Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma

I. Pollack, G. Dhall, C. Kretschmar, 2012, Pediatric blood & cancer.

Dose-intensive, Time-compressed Procarbazine, CCNU, Vincristine (PCV) with Peripheral Blood Stem Cell Support and Concurrent Radiation in Patients with Newly Diagnosed High-grade Gliomas

Jeffrey C. Allen, L. Velasquez, R. Jakacki, 1999, Journal of Neuro-Oncology.

Adding α -difluoromethylornithine to procarbazine, N -(2-chloroethyl)-N ′-cyclohexyl- N -nitrosurea and vincristine (PCV) chemotherapy has no benefit in postradiotherapy treatment of glioblastoma multiforme

R. Jakacki, 2001 .

NF1 plexiform neurofibroma growth rate by volumetric MRI

S. Steinberg, B. Korf, F. Balis, 2007, Neurology.

Neurocutaneous melanosis is associated with tethered spinal cord

M. Reyes-Múgica, R. Jakacki, Kimberly A. Foster, 2014, Child's Nervous System.

Stereotactic radiosurgery for pilocytic astrocytomas part 2: outcomes in pediatric patients

D. Kondziolka, J. Flickinger, L. Lunsford, 2009, Journal of Neuro-Oncology.

Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group.

L. Rorke, J. Wisoff, A. L. Albright, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intracranial Germ Cell Tumors

I. Pollack, Y. Sawamura, N. Tribolet, 2011 .

Central nervous system germ cell tumors

R. Jakacki, 2002, Current treatment options in neurology.

Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: A report from the children's oncology group

D. Brat, T. Zhou, F. Gilles, 2010, Pediatric blood & cancer.

Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors.

I. Pollack, J. Fangusaro, S. Kaste, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-Grade Gliomas

C. Q. Lee, David T. W. Jones, Michael D. Brooks, 2012, Oxford Medicine Online.

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children’s Oncology Group

D. Brat, T. Zhou, M. Rosenblum, 2010, Child's Nervous System.

Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy

I. Pollack, H. Okada, R. Hamilton, 2012, Journal of Neuro-Oncology.

Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study.

Mark D Krailo, Marta Hamilton, J. Dancey, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

J. Finlay, G. Reaman, R. Packer, 1997, Journal of neurosurgery.

TITLE : Natural History of Plexiform Neurofibromas in NF 1 PRINCIPAL INVESTIGATOR :

S. Steinberg, B. Korf, F. Balis, 2009 .

Childhood brain tumors: epidemiology, current management and future directions

I. Pollack, R. Jakacki, 2011, Nature Reviews Neurology.

TR-14A FEASIBILITY AND RANDOMIZED PHASE II STUDY OF VORINOSTAT, BEVACIZUMAB, OR TEMOZOLOMIDE DURING RADIATION FOLLOWED BY MAINTENANCE CHEMOTHERAPY IN NEWLY-DIAGNOSED PEDIATRIC HIGH-GRADE GLIOMA: CHILDREN'S ONCOLOGY GROUP STUDY ACNS0822

I. Pollack, D. Boue, D. Haas-Kogan, 2015 .

A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study.

I. Pollack, A. Ligon, N. Lindeman, 2017 .

Peptide vaccine therapy for childhood gliomas.

I. Pollack, L. Butterfield, H. Okada, 2013, Neurosurgery.

Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018.

T. MacDonald, I. Pollack, J. Fangusaro, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab.

R. Packer, R. Avery, E. Hwang, 2014, JAMA ophthalmology.

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.

D. Brat, T. Zhou, M. Rosenblum, 2016, Neuro-oncology.

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma : a report of the Children ’ s Oncology Group ACNS 0423 study

D. Brat, T. Zhou, M. Rosenblum, 2016 .

Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children’s Oncology Group

D. Brat, T. Zhou, M. Rosenblum, 2010, Journal of Neuro-Oncology.

Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.

V. Mathews, D. Heilman, T. Luerssen, 2000, Journal of neurosurgery.

Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.

A. Panigrahy, A. Furtado, S. Blüml, 2017, Neuroimaging clinics of North America.

Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: A report from the Children's Oncology Group

M. Mehta, I. Pollack, P. Burger, 2015, Pediatric blood & cancer.

A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).

M. Prados, Douglas C. Miller, M. Mehta, 2009, International journal of radiation oncology, biology, physics.

Ependymomas: development of immunotherapeutic strategies

I. Pollack, L. Butterfield, H. Okada, 2013, Expert review of neurotherapeutics.

Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group

S. Steinberg, F. Balis, B. Widemann, 2006, Cancer Chemotherapy and Pharmacology.

Phase 1 study of concurrent RMP‐7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas

M. Mehta, G. Reaman, R. Packer, 2005, Cancer.

Treatment of standard risk medulloblastoma with craniospinal irradiation, carboplatin, and vincristine.

J. Finlay, G. Heller, R. Jakacki, 1997, Medical and pediatric oncology.

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.

I. Pollack, H. Friedman, A. Murgo, 2007, Neuro-oncology.

Recurrent medulloblastoma following pediatric double-lung transplant.

G. Kurland, R. Jakacki, S. Kapoor, 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma

I. Pollack, M. Nikiforova, S. Ferrone, 2013, Clinical Cancer Research.

Imaging , Diagnosis , Prognosis LOH in the HLA Class I Region at 6 p 21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma

I. Pollack, M. Nikiforova, S. Ferrone, 2013 .

Melanotic neuroectodermal tumor of infancy.

R. Jakacki, M. Edwards, J. C. George, 1995, AJNR. American journal of neuroradiology.

Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer

P. Adamson, F. Balis, R. Packer, 2003, Cancer Chemotherapy and Pharmacology.

A phase 1 study of AZD6244 in children with recurrent or refractory low-grade gliomas: A Pediatric Brain Tumor Consortium report.

M. Prados, I. Pollack, L. Doyle, 2014 .

Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults.

J. Silber, G. Barber, V. Vetter, 1992, The American journal of cardiology.

Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antigen Peptide Vaccines

A. Panigrahy, S. Bluml, I. Pollack, 2022, Cancers.

A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors

S. Vajapeyam, M. Moses, R. Packer, 2015, Child's Nervous System.

LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B

David T. W. Jones, A. Panigrahy, S. Pfister, 2019, Neuro-Oncology.

Bevacizumab for symptomatic radiation‐induced tumor enlargement in pediatric low grade gliomas

I. Pollack, W. Ares, R. Jakacki, 2015, Pediatric blood & cancer.

Pseudoprogression of low‐grade gliomas after radiotherapy

I. Pollack, M. Deutsch, R. Naftel, 2015, Pediatric blood & cancer.

High grade gliomas

C. Q. Lee, David T. W. Jones, Michael D. Brooks, 2022, Progress in Brain Research.

Neuro-onc Ology Phase I Trial of Imatinib in Children with Newly Diagnosed Brainstem and Recurrent Malignant Gliomas: a Pediatric Brain Tumor Consortium Report 1

M. Kieran, T. Poussaint, M. Krasin, 2006 .

Bevacizumab for symptomatic radiation‐induced tumor enlargement in pediatric low grade gliomas

I. Pollack, W. Ares, R. Jakacki, 2015, Pediatric blood & cancer.

Bevacizumab (BVZ)‐associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT‐11)

R. McLendon, I. Pollack, R. Gilbertson, 2013, Cancer.

142. Adult medulloblastoma

A. Brandes, E. Franceschi, R. Jakacki, 2016 .